YAP-TEAD interaction inhibitor (Bao Kang Biomedical Healthcare)

N/A

Report date: 2025/03/19 11:41:48

Base Information

Drug NameYAP-TEAD interaction inhibitor (Bao Kang Biomedical Healthcare)
Drug Alias NameYAP-TEAD protein-protein interaction inhibitor (Bao Kang Biomedical Healthcare)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTranscriptional enhancer factor inhibitorsTranscriptional coactivator YAP1 inhibitors
TargetsTranscriptional enhancer factorTranscriptional coactivator YAP1
Therapy Area/IndicationsMesothelioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBao Kang Biomedical Healthcare Inc
China Registration ClassN/A

Develop Information

Active CompaniesBao Kang Biomedical Healthcare Inc
Inactive CompaniesN/A
Active IndicationsMesothelioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A